NEW YORK, August 24, 2021 / PRNewswire / - Zeamo, an enterprise wellness platform, today announced the launch of fifty new partnerships and integrations,...
Patients with chronic kidney disease and type 2 diabetes who took the experimental drug finerenone developed about a 30% less chance of developing atrial...